A new trading day began on Monday, with Kala Bio Inc (NASDAQ: KALA) stock price down -10.58% from the previous day of trading, before settling in for the closing price of $0.65. KALA’s price has ranged from $0.51 to $20.60 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 40.66% over the past five years. Meanwhile, its annual earnings per share averaged 56.16%. With a float of $17.78 million, this company’s outstanding shares have now reached $21.93 million.
Kala Bio Inc (KALA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Kala Bio Inc is 18.91%, while institutional ownership is 4.76%. The most recent insider transaction that took place on Oct 23 ’25, was worth 125,464. In this transaction Director of this company sold 154,894 shares at a rate of $0.81, taking the stock ownership to the 103,540 shares. Before that another transaction happened on Oct 22 ’25, when Company’s CHIEF FINANCIAL OFFICER sold 32,230 for $0.83, making the entire transaction worth $26,751. This insider now owns 29,873 shares in total.
Kala Bio Inc (KALA) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -1.23 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 65.97% during the next five years compared to 40.66% growth over the previous five years of trading.
Kala Bio Inc (NASDAQ: KALA) Trading Performance Indicators
Here are Kala Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.94, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Kala Bio Inc (KALA)
Kala Bio Inc (NASDAQ: KALA) saw its 5-day average volume 1.41 million, a negative change from its year-to-date volume of 2.15 million. As of the previous 9 days, the stock’s Stochastic %D was 52.69%.
During the past 100 days, Kala Bio Inc’s (KALA) raw stochastic average was set at 0.35%, which indicates a significant decrease from 20.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0854 in the past 14 days, which was lower than the 0.6063 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7647, while its 200-day Moving Average is $5.0628. Nevertheless, the first resistance level for the watch stands at $0.6271 in the near term. At $0.6730, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6960. If the price goes on to break the first support level at $0.5582, it is likely to go to the next support level at $0.5352. The third support level lies at $0.4893 if the price breaches the second support level.
Kala Bio Inc (NASDAQ: KALA) Key Stats
With a market capitalization of 12.74 million, the company has a total of 9,830K Shares Outstanding. Currently, annual sales are 0 K while annual income is -38,510 K. The company’s previous quarter sales were 0 K while its latest quarter income was -7,560 K.
